Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Oncotarget|January 20, 2018
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMTGabrielle Roth-Guepin, Jonathan Canaani, Annalisa Ruggeri, et al.Journal of Hematology & Oncology|April 2, 2021
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Mohamed Houhou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.British Journal of Haematology|May 23, 2024
Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemiaEitan Kugler, Inbar Cohen, Irina Amitai, et al.Blood Advances|December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort studyOfir Wolach, Itai Levi, Boaz Nachmias, et al.American Journal of Hematology|April 26, 2017
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMTJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.Transplantation and Cellular Therapy|August 28, 2022
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.Transplantation and Cellular Therapy|December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.Cancer Discovery|May 16, 2019
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid LeukemiaChristine M McMahon, Timothy Ferng, Jonathan Canaani, et al.Pageof 6